🔎 Trials Near Me

Akèy › Obèsite › Michigan › Troy

Etid klinik pou Obèsite nan Troy, MI

9 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote Troy (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Ap rekriteFaz 3
  • Arcturus Healthcare , PLC, Troy Internal Medicine Research Division, Troy
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Ap rekriteFaz 3
  • Arcturus Healthcare , PLC, Troy Internal Medicine Research Division, Troy
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07321886

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Ap rekriteFaz 2
  • Arcturus Healthcare , PLC, Troy Internal Medicine Research Division, Troy
Laj 18 a 75 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589608

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Ap rekriteFaz 3
  • Advanced Cardiology Associates, Rochester Hills · 4 mi lwen
  • Embassy Research Network, Bloomfield Township · 7 mi lwen
Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT07037459

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Ap rekriteFaz 2
  • Arcturus Healthcare , PLC, Troy Internal Medicine Research Division, Troy
Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT06143956

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Ap rekriteFaz 3
  • Arcturus Healthcare, Public Limited Company, Troy Internal Medicine Research Division, Troy
Laj 18 a 99 · Tout sèks · Mizajou Aug 27, 2026 · NCT07575399

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Ap rekriteFaz 3
  • Research Site, Troy
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT07784725

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Ap rekriteFaz 3
  • Cardio and Vascular Assoc-CAVA, Bloomfield Hills · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07567001

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Ap rekriteFaz 3
  • Arcturus Healthcare, PLC., Troy
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT07509307

Etid Obèsite nan lòt vil

Lòt etid nan Troy

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.